Evidence map›Paper›PMID 41113076›Full record

ArticleWorld journal of clinical cases2025

Recurrent dermatofibrosarcoma protuberans involving the lacrimal sac: A case report.

Bijnya Birajita Panda, Sudhakar Gunasekar, Utkarsh Agarwal, Thilakraj Koppalu Lingaraju, Amit Kumar Adhya

Abstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bijnya Birajita PandaDepartment of Ophthalmology, All India Institute of Medical Sciences, Bhubaneshwar 751019, Odisha, India. bigyan_panda@yahoo.co.in.
Sudhakar GunasekarDepartment of Surgical Oncology, Jawaharlal Institute of Postgraduate Medical Education & Research, Tamil Nadu 110029, India.
Utkarsh AgarwalDepartment of Ophthalmology, All India Institute of Medical Sciences, Bhubaneshwar 751019, Odisha, India.
Thilakraj Koppalu LingarajuDepartment of Ophthalmology, All India Institute of Medical Sciences, Bhubaneshwar 751019, Odisha, India.
Amit Kumar AdhyaDepartment of Pathology, All India Institute of Medical Sciences, Bhubaneshwar 751019, Odisha, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDermatofibrosarcoma protuberans (DFSP) is a rare, low-grade, locally aggressive cutaneous sarcoma. DFSP in the periocular region is exceedingly rare, leading to diagnostic and surgical challenges due to anatomical constraints in the periocular region. Precise diagnosis is essential to guide appropriate surgical management and prevent recurrence. CASE SUMMARY: A 32-year-old female presented with a recurrent tumor in the medial canthus, previously diagnosed as a solitary fibrous tumor in an outside institution. After complete radiological and systemic workup, she was scheduled for a wide local excision followed by reconstruction after getting tumor clear margins on frozen section. Histopathology confirmed DFSP, characterized by storiform spindle cell proliferation, diffuse cluster of differentiation 34 positivity, and signal transducer and activator of transcription 6 negativity.

conclusionThis case highlights the challenges in the diagnostic and surgical management of DFSP in periocular tumors. Comprehensive surgical excision with appropriate reconstruction is critical for achieving oncological control while preserving aesthetics and function.

Indexed as

Case reportCluster of differentiation 34Dermatofibrosarcoma protuberansMedial canthus tumorSignal transducer and activator of transcription 6Solitary fibrous tumorWide local excision

Identifiers

PMID41113076
PMCPMC12531683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.